Prevalence and Incidence of Psoriatic Arthritis among Patients with Psoriasis and Risk Factors for Psoriatic Arthritis in Republic of Korea: A Nationwide Database Cohort Study
Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited, especially in Asian populations. Therefore, the aim was to determine the prevalence and incidence of PsA among PsO patients in Korea, and examine as...
Saved in:
Published in | Acta dermato-venereologica Vol. 104; p. adv40110 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Sweden
MJS Publishing, on behalf of the Society for Publication of Acta Dermato-Venereologica
19.09.2024
Medical Journals Sweden |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited, especially in Asian populations. Therefore, the aim was to determine the prevalence and incidence of PsA among PsO patients in Korea, and examine associated clinical factors. A cohort study was performed to determine the annual prevalence and incidence of PsA among PsO patients between 2008 and 2020 using nationwide claims data in Korea. Risk factors for PsA development were also examined using logistic regression among matched PsA cases and controls. An increasing trend in PsA prevalence per 1,000 patients was observed; prevalence was 6.17 (95% confidence interval [CI] 5.73-6.65) in 2008 and 19.03 (95% CI 18.39-19.70) in 2020. Similarly, the PsA incidence rate per 1,000 patient-years increased from 3.35 (95% CI 3.01-3.72) in 2008 to 5.01 (95% CI 4.68-5.36) in 2020. Patients with plaque PsO, moderate-to severe PsO, receiving oral systemic therapy or phototherapy, with a higher burden of comorbidities, and concomitant autoimmune diseases had a higher risk of PsA. The results provide insight into the burden of PsA among PsO patients in Korea and risk factors associated with developing PsA. |
---|---|
AbstractList | Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited, especially in Asian populations. Therefore, the aim was to determine the prevalence and incidence of PsA among PsO patients in Korea, and examine associated clinical factors. A cohort study was performed to determine the annual prevalence and incidence of PsA among PsO patients between 2008 and 2020 using nationwide claims data in Korea. Risk factors for PsA development were also examined using logistic regression among matched PsA cases and controls. An increasing trend in PsA prevalence per 1,000 patients was observed; prevalence was 6.17 (95% confidence interval [CI] 5.73–6.65) in 2008 and 19.03 (95% CI 18.39–19.70) in 2020. Similarly, the PsA incidence rate per 1,000 patient-years increased from 3.35 (95% CI 3.01–3.72) in 2008 to 5.01 (95% CI 4.68–5.36) in 2020. Patients with plaque PsO, moderate-to severe PsO, receiving oral systemic therapy or phototherapy, with a higher burden of comorbidities, and concomitant autoimmune diseases had a higher risk of PsA. The results provide insight into the burden of PsA among PsO patients in Korea and risk factors associated with developing PsA.
We observed an increase in prevalence and incidence of psoriatic arthritis among psoriasis patients over time in Korea and examined associated risk factors for psoriatic arthritis development. These data help understand the increasing burden of psoriatic arthritis in Korean psoriasis patients and identify patients at higher risk for psoriatic arthritis. Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited, especially in Asian populations. Therefore, the aim was to determine the prevalence and incidence of PsA among PsO patients in Korea, and examine associated clinical factors. A cohort study was performed to determine the annual prevalence and incidence of PsA among PsO patients between 2008 and 2020 using nationwide claims data in Korea. Risk factors for PsA development were also examined using logistic regression among matched PsA cases and controls. An increasing trend in PsA prevalence per 1,000 patients was observed; prevalence was 6.17 (95% confidence interval [CI] 5.73–6.65) in 2008 and 19.03 (95% CI 18.39–19.70) in 2020. Similarly, the PsA incidence rate per 1,000 patient-years increased from 3.35 (95% CI 3.01–3.72) in 2008 to 5.01 (95% CI 4.68–5.36) in 2020. Patients with plaque PsO, moderate-to severe PsO, receiving oral systemic therapy or phototherapy, with a higher burden of comorbidities, and concomitant autoimmune diseases had a higher risk of PsA. The results provide insight into the burden of PsA among PsO patients in Korea and risk factors associated with developing PsA. Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited, especially in Asian populations. Therefore, the aim was to determine the prevalence and incidence of PsA among PsO patients in Korea, and examine associated clinical factors. A cohort study was performed to determine the annual prevalence and incidence of PsA among PsO patients between 2008 and 2020 using nationwide claims data in Korea. Risk factors for PsA development were also examined using logistic regression among matched PsA cases and controls. An increasing trend in PsA prevalence per 1,000 patients was observed; prevalence was 6.17 (95% confidence interval [CI] 5.73-6.65) in 2008 and 19.03 (95% CI 18.39-19.70) in 2020. Similarly, the PsA incidence rate per 1,000 patient-years increased from 3.35 (95% CI 3.01-3.72) in 2008 to 5.01 (95% CI 4.68-5.36) in 2020. Patients with plaque PsO, moderate-to severe PsO, receiving oral systemic therapy or phototherapy, with a higher burden of comorbidities, and concomitant autoimmune diseases had a higher risk of PsA. The results provide insight into the burden of PsA among PsO patients in Korea and risk factors associated with developing PsA.Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited, especially in Asian populations. Therefore, the aim was to determine the prevalence and incidence of PsA among PsO patients in Korea, and examine associated clinical factors. A cohort study was performed to determine the annual prevalence and incidence of PsA among PsO patients between 2008 and 2020 using nationwide claims data in Korea. Risk factors for PsA development were also examined using logistic regression among matched PsA cases and controls. An increasing trend in PsA prevalence per 1,000 patients was observed; prevalence was 6.17 (95% confidence interval [CI] 5.73-6.65) in 2008 and 19.03 (95% CI 18.39-19.70) in 2020. Similarly, the PsA incidence rate per 1,000 patient-years increased from 3.35 (95% CI 3.01-3.72) in 2008 to 5.01 (95% CI 4.68-5.36) in 2020. Patients with plaque PsO, moderate-to severe PsO, receiving oral systemic therapy or phototherapy, with a higher burden of comorbidities, and concomitant autoimmune diseases had a higher risk of PsA. The results provide insight into the burden of PsA among PsO patients in Korea and risk factors associated with developing PsA. |
Author | Jung, Eun Suk Kim, Jung-Ae Kim, Yoon-Seob An, Jihye Park, Chul Jong Ahn, JiYoon Bang, Chul Hwan |
Author_xml | – sequence: 1 givenname: Chul Hwan surname: Bang fullname: Bang, Chul Hwan organization: Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea – sequence: 2 givenname: Yoon-Seob surname: Kim fullname: Kim, Yoon-Seob organization: Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea – sequence: 3 givenname: Jihye surname: An fullname: An, Jihye organization: Janssen Korea Ltd., Seoul, Republic of Korea – sequence: 4 givenname: Eun Suk surname: Jung fullname: Jung, Eun Suk organization: Janssen Korea Ltd., Seoul, Republic of Korea – sequence: 5 givenname: JiYoon surname: Ahn fullname: Ahn, JiYoon organization: IQVIA Solutions Korea Ltd, Seoul, Republic of Korea – sequence: 6 givenname: Jung-Ae surname: Kim fullname: Kim, Jung-Ae organization: IQVIA Solutions Korea Ltd, Seoul, Republic of Korea; Department of Pharmaceutical Engineering, Inje University, Gimhae, Republic of Korea – sequence: 7 givenname: Chul Jong surname: Park fullname: Park, Chul Jong email: cjpark777smp@gmail.com organization: Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. cjpark777smp@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39295582$$D View this record in MEDLINE/PubMed |
BookMark | eNptkstuUzEQhi1URNPCA7BBXrJJ8O2c48MGVYFCRAVRgbU18SVxObGL7aTqU_GKOBcqKuGNNTO_v5mx_jN0EmKwCL2kZMK4IG9AFzDbyZYSMRGEUvIEjWjb0DEjTXeCRoQQOm7qOUVnOd_UkDVUPkOnvGd900g2Qr_nyW5hsEFbDMHgWdDe7KPo8DzH5KF4jS9SWSVffMawjmGJ5zVrQ8n4zpfVUZd31Yq49vknvqyzxZSxi-m_GB_wtb3dLIaarZ0-x2ThLb7AX6ouhrs6A34PBRaQLZ7GVUwFfysbc_8cPXUwZPvieJ-jH5cfvk8_ja--fpxNL67GmgtZxrInzmhBbUsoc1BXJUAMNM5a45iUQhC20KSTkgN0jhrWu5ZTIWQnNbSan6PZgWsi3Kjb5NeQ7lUEr_aJmJYKUl1psIoy0E1PCem6hWgIhwYW1hnDe2N5J3llvTuw6r5ra3T9uATDI-jjSvArtYxbRamgknU7wusjIcVfG5uLWvus7TBAsHGTFaek7bigraxSepDqFHNO1j30oUTtXKMOrlE716i9a-qbV_8O-PDir034H7mKxNs |
Cites_doi | 10.1002/art.39530 10.3346/jkms.2017.32.5.718 10.1016/j.jid.2021.11.018 10.1186/s13075-017-1497-4 10.1016/j.jaut.2016.10.009 10.1016/j.jaad.2013.07.023 10.1007/s00296-020-04775-2 10.1111/bjd.17832 10.1016/j.jaad.2018.06.027 10.3390/jcm11133744 10.1136/bmj.m1590 10.3906/sag-2011-235 10.1007/s002960050109 10.1136/annrheumdis-2012-201706 10.1002/art.41946 10.1136/annrheumdis-2017-211625 10.1093/oxfordjournals.aje.a009786 10.1002/acr.20401 10.1007/s40744-021-00378-w 10.1093/aje/kwq433 10.1136/rmdopen-2023-003166 10.1136/bmjopen-2014-006450 10.18553/jmcp.2004.10.4.318 10.7570/jomes22024 10.3899/jrheum.2023-0506 10.1097/01.mlr.0000182534.19832.83 10.1111/j.1468-3083.2009.03463.x 10.1214/09-STS313 10.1007/s11926-015-0540-1 10.1016/j.jaad.2005.10.008 10.1002/acr.23743 10.1016/S2665-9913(23)00055-3 10.1016/j.jaad.2015.05.001 10.1001/jamadermatol.2022.1081 10.1016/j.jid.2016.11.032 10.1111/jdv.13210 10.1007/s13555-018-0266-x 10.3390/ijms23147499 10.1111/jdv.14979 10.2340/actadv.v102.1962 10.1093/rheumatology/keg217 |
ContentType | Journal Article |
Copyright | 2024 The Author(s) 2024 |
Copyright_xml | – notice: 2024 The Author(s) 2024 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.2340/actadv.v104.40110 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1651-2057 |
ExternalDocumentID | oai_doaj_org_article_12ac5910077b4503a5abefdd39de3783 10_2340_actadv_v104_40110 39295582 |
Genre | Journal Article |
GeographicLocations | Republic of Korea |
GeographicLocations_xml | – name: Republic of Korea |
GroupedDBID | --- 23M 36B 5GY 5RE 5VS 6J9 ABDBF ABOCM ACGFO AEGXH AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS B0M CGR CS3 CUY CVF DIK E3Z EAD EAP EBC EBD EBS EBX ECM EIF EJD EMB EMK EMOBN ESX F5P FIJ GROUPED_DOAJ GX1 H13 HF~ IPNFZ KQ8 L7B MSJ M~E NPM OK1 P2P P6G RIG RNS RPM SV3 TR2 TUS ~8M AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c348t-890fdc41e6012fa5820a0da5feedf2884402bc07883aa7f1d29f63144878ca6c3 |
IEDL.DBID | RPM |
ISSN | 0001-5555 1651-2057 |
IngestDate | Mon Sep 23 19:32:59 EDT 2024 Tue Sep 24 05:24:45 EDT 2024 Thu Sep 26 11:46:57 EDT 2024 Wed Sep 25 14:11:46 EDT 2024 Tue Oct 15 08:49:01 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c348t-890fdc41e6012fa5820a0da5feedf2884402bc07883aa7f1d29f63144878ca6c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418273/ |
PMID | 39295582 |
PQID | 3106734168 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_12ac5910077b4503a5abefdd39de3783 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11418273 proquest_miscellaneous_3106734168 crossref_primary_10_2340_actadv_v104_40110 pubmed_primary_39295582 |
PublicationCentury | 2000 |
PublicationDate | 20240919 |
PublicationDateYYYYMMDD | 2024-09-19 |
PublicationDate_xml | – month: 9 year: 2024 text: 20240919 day: 19 |
PublicationDecade | 2020 |
PublicationPlace | Sweden |
PublicationPlace_xml | – name: Sweden |
PublicationTitle | Acta dermato-venereologica |
PublicationTitleAlternate | Acta Derm Venereol |
PublicationYear | 2024 |
Publisher | MJS Publishing, on behalf of the Society for Publication of Acta Dermato-Venereologica Medical Journals Sweden |
Publisher_xml | – name: MJS Publishing, on behalf of the Society for Publication of Acta Dermato-Venereologica – name: Medical Journals Sweden |
References | 75607 75606 75605 75604 75603 75569 75602 75568 75601 75567 75600 75566 75565 75564 75563 75562 75561 75560 75539 75616 75538 75615 75537 75614 75536 75613 75535 75579 75612 75534 75578 75611 75577 75610 75576 75575 75574 75573 75572 75571 75570 75609 75608 75549 75548 75547 75546 75545 75589 75544 75588 75543 75587 75542 75586 75541 75585 75540 75584 75583 75582 75581 75580 75559 75558 75557 75556 75555 75599 75554 75598 75553 75597 75552 75596 75551 75595 75550 75594 75593 75592 75591 75590 |
References_xml | – ident: 75569 doi: 10.1002/art.39530 – ident: 75555 doi: 10.3346/jkms.2017.32.5.718 – ident: 75595 doi: 10.1016/j.jid.2021.11.018 – ident: 75546 doi: 10.1186/s13075-017-1497-4 – ident: 75550 doi: 10.1016/j.jaut.2016.10.009 – ident: 75537 doi: 10.1016/j.jaad.2013.07.023 – ident: 75605 doi: 10.1007/s00296-020-04775-2 – ident: 75600 doi: 10.1111/bjd.17832 – ident: 75553 doi: 10.1016/j.jaad.2018.06.027 – ident: 75564 doi: 10.3390/jcm11133744 – ident: 75577 doi: 10.1136/bmj.m1590 – ident: 75606 doi: 10.3906/sag-2011-235 – ident: 75567 doi: 10.1007/s002960050109 – ident: 75588 doi: 10.1136/annrheumdis-2012-201706 – ident: 75590 doi: 10.1002/art.41946 – ident: 75576 doi: 10.1136/bmj.m1590 – ident: 75544 doi: 10.1136/annrheumdis-2017-211625 – ident: 75556 doi: 10.1093/oxfordjournals.aje.a009786 – ident: 75570 doi: 10.1002/acr.20401 – ident: 75541 doi: 10.1007/s40744-021-00378-w – ident: 75563 doi: 10.1093/aje/kwq433 – ident: 75594 doi: 10.1016/j.jid.2021.11.018 – ident: 75609 doi: 10.1136/rmdopen-2023-003166 – ident: 75575 doi: 10.1136/bmjopen-2014-006450 – ident: 75592 doi: 10.18553/jmcp.2004.10.4.318 – ident: 75582 doi: 10.7570/jomes22024 – ident: 75614 doi: 10.3899/jrheum.2023-0506 – ident: 75561 doi: 10.1097/01.mlr.0000182534.19832.83 – ident: 75538 doi: 10.1111/j.1468-3083.2009.03463.x – ident: 75568 doi: 10.1002/art.39530 – ident: 75559 doi: 10.1214/09-STS313 – ident: 75552 doi: 10.1016/j.jaad.2018.06.027 – ident: 75539 doi: 10.1111/j.1468-3083.2009.03463.x – ident: 75574 doi: 10.1136/bmjopen-2014-006450 – ident: 75586 doi: 10.1007/s11926-015-0540-1 – ident: 75615 doi: 10.1016/j.jaad.2005.10.008 – ident: 75593 doi: 10.18553/jmcp.2004.10.4.318 – ident: 75601 doi: 10.1111/bjd.17832 – ident: 75578 doi: 10.1002/acr.23743 – ident: 75612 doi: 10.1016/S2665-9913(23)00055-3 – ident: 75611 doi: 10.1016/S2665-9913(23)00055-3 – ident: 75548 doi: 10.1016/j.jaad.2015.05.001 – ident: 75589 doi: 10.1136/annrheumdis-2012-201706 – ident: 75602 doi: 10.1001/jamadermatol.2022.1081 – ident: 75542 doi: 10.1016/j.jid.2016.11.032 – ident: 75580 doi: 10.1111/jdv.13210 – ident: 75560 doi: 10.1097/01.mlr.0000182534.19832.83 – ident: 75545 doi: 10.1136/annrheumdis-2017-211625 – ident: 75599 doi: 10.1007/s13555-018-0266-x – ident: 75587 doi: 10.1007/s11926-015-0540-1 – ident: 75607 doi: 10.3906/sag-2011-235 – ident: 75583 doi: 10.7570/jomes22024 – ident: 75551 doi: 10.1016/j.jaut.2016.10.009 – ident: 75566 doi: 10.1007/s002960050109 – ident: 75604 doi: 10.1007/s00296-020-04775-2 – ident: 75584 doi: 10.3390/ijms23147499 – ident: 75549 doi: 10.1016/j.jaad.2015.05.001 – ident: 75579 doi: 10.1002/acr.23743 – ident: 75554 doi: 10.3346/jkms.2017.32.5.718 – ident: 75558 doi: 10.1214/09-STS313 – ident: 75616 doi: 10.1016/j.jaad.2005.10.008 – ident: 75597 doi: 10.1111/jdv.14979 – ident: 75573 doi: 10.2340/actadv.v102.1962 – ident: 75603 doi: 10.1001/jamadermatol.2022.1081 – ident: 75596 doi: 10.1111/jdv.14979 – ident: 75543 doi: 10.1016/j.jid.2016.11.032 – ident: 75562 doi: 10.1093/aje/kwq433 – ident: 75557 doi: 10.1093/oxfordjournals.aje.a009786 – ident: 75613 doi: 10.3899/jrheum.2023-0506 – ident: 75536 doi: 10.1016/j.jaad.2013.07.023 – ident: 75591 doi: 10.1002/art.41946 – ident: 75608 – ident: 75610 doi: 10.1136/rmdopen-2023-003166 – ident: 75540 doi: 10.1007/s40744-021-00378-w – ident: 75572 doi: 10.2340/actadv.v102.1962 – ident: 75534 doi: 10.1093/rheumatology/keg217 – ident: 75565 doi: 10.3390/jcm11133744 – ident: 75585 doi: 10.3390/ijms23147499 – ident: 75535 doi: 10.1093/rheumatology/keg217 – ident: 75598 doi: 10.1007/s13555-018-0266-x – ident: 75547 doi: 10.1186/s13075-017-1497-4 – ident: 75571 doi: 10.1002/acr.20401 – ident: 75581 doi: 10.1111/jdv.13210 |
SSID | ssj0002518 |
Score | 2.4486423 |
Snippet | Population-based epidemiological studies on disease burden and risk factors for psoriatic arthritis (PsA) in patients with psoriasis (PsO) are limited,... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | adv40110 |
SubjectTerms | Adult Aged Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - epidemiology Comorbidity Databases, Factual Epidemiology Female Humans Incidence Male Middle Aged Original Report Prevalence Psoriasis Psoriasis - diagnosis Psoriasis - epidemiology Psoriatic arthritis Republic of Korea - epidemiology Risk Assessment Risk factor Risk Factors Severity of Illness Index Time Factors Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1da9YwFA6yC_FGdH5V3YjgldCtbT6aeDc3X4YyGcPB7sppPnhfBq2s3cRf5V_0nKbv2CsDb-xlm6Yh5yTneZrkOYy9L6qAqEHH3MSgc6mUzw3UOretEhHhhJOKzjuffNPH5_LLhbq4k-qL9oQleeDUcftlBU5ZWsuvW6kKAQraEL0X1gdRm6TzWao1mZrnYIzaaQ5GsqzwSuuZlZDFPrgR_M3eDfKQPUnRbyMiTcL996HNvzdN3olCiyfs8Qwf-UFq9lP2IHTb7OHJvED-jP0mSSaYDhJx6DzH4Z-yhvI-8tOhvyJLOHp_OakZ8SnZED9N6qoDp9-yc7mBnmIVZ6vhki9SWh6OEPfealYdPwtJMpu-9LVHLPqRH_Aku_0T28CPYASKmfywXyLm57SD8ddzdr74_P3wOJ9zMuROSDPmxhbRO1kGJHJVBIUAAgoPKmKsjZUxEvlo6xB3GAFQx9JXNmqBrM3UxoF24gXb6vouvGLc6xYQMFTRaSOxsMU5O2jrfLSttKXI2Ie1XZofSXqjQcpCRmySERsyYjMZMWOfyHK3BUk1e7qBvtTMvtT8y5cy9m5t9wZHGS2dQBf666ERpLSHAV-bjL1MfnD7KUKYCjsiY2bDQzbasvmkWy0nJW8ko8jvavH6f7T-DXtUIeKizSylfcu2xqvrsIOIaWx3p8HxB6hMFk4 priority: 102 providerName: Directory of Open Access Journals |
Title | Prevalence and Incidence of Psoriatic Arthritis among Patients with Psoriasis and Risk Factors for Psoriatic Arthritis in Republic of Korea: A Nationwide Database Cohort Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39295582 https://www.proquest.com/docview/3106734168/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC11418273 https://doaj.org/article/12ac5910077b4503a5abefdd39de3783 |
Volume | 104 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHqpeEG-WR2UkTkjZTeJHbG5lYVWBFq0qKvVmOX6wK2hSbdIifhV_kbGdVCzqiRwTv5QZe76xx98g9CYvHaAG7jPhHc8oYzYTuuKZrBnxACcMZeG-8_ILPz2nny7YxR7i412YGLRv6s20-XE5bTbrGFt5dWlmY5zYbLWcA4YHWFyR2T7arwgZffRh_QWLndZfcJQZPOkssyQ0n2nTa3szvQEfZEqD5TtChwEgMCbKHcMU-fvvAp3_xk7-ZYwW99G9AUXikzTaB2jPNQ_R4XI4J3-EfgdmJh3vE2HdWAyrQEoeiluPV127DQIxof46khrhmHMIrxLJaofD7uxQrgtfoYmzTfcdL1J2HgxI985mNg0-c4k5O_T0uQVI-g6f4MS-_RPGgD_oXgfTieftGqA_DoGMvx6j88XHr_PTbEjNkBlCRZ8JmXtraOHAnyu9ht-X69xq5sHk-lIICm5pbQB-CKJ15QtbSs8JOG-iEkZzQ56gg6Zt3DOELa814IbSGy4oFJawdDsujfWyprIgE_R2lIu6SgwcCjyXIE-V5KmCPFWU5wS9D5K7LRjIs-OLdvtNDSqkilIbJkN4SFVTlhPNdO28tURaRyoBPb4e5a5gsoUTFN249rpTJBDugd3nYoKeJj247WrUowkSOxqyM5bdL6DfkdB71Ofn_1_1BToqAW6FSJZCvkQH_fbavQK41NfHcZvhOM6RP9XaGBk |
link.rule.ids | 230,315,733,786,790,870,891,2115,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGkMZexnXQcTMST0hJk_gSh7dRqApbp2raxN4ixxdajSVTkw7Bn-IvchwnE532AnmM7diWP_t8Jz7-jNDbKDHAGrgNhDU8oIzpQMiUB1nBiAU6oShz552nR3xySr-csbMNxPuzMG3QvioWYfn9IiwX8za28vJCDfs4seFsOgIOD7Q4JcM76C5M2IT1Xnq3AoPN9iswuMoMHr-bmRAaDaVqpL4Kr8ALCamzfdtoy1EExkSyZppaBf_baOfN6Mm_zNH4Pvrad8RHoZyHq6YI1a8bGo__3tMHaKdjqHjfpz9EG6Z8hLam3R78Y_TbqT7J9qwSlqXGsML4i0lxZfGsrpZusJUrP28Fk3B7nxGeeQHXGrs_v12-2qXCJ44X9Tke-5t_MLDoWz-zKPGx8arcrqaDCujue7yPvbL3D2gD_igb6cwyHlVzcCuwC5L8-QSdjj-djCZBd-1DoAgVTSCyyGpFYwO-YmIlDEwkIy2ZBXNuEyEouLyFAmojiJSpjXWSWU7AMRSpUJIrsos2y6o0zxDWvJDASRKruKCQOQOzYHimtM0KmsVkgN71I55fenWPHLwih5TcIyV3SMlbpAzQB4eJ64xOmLt9US2_5d2g5XEiFctc6ElaUBYRyWRhrNYk04akAmp80yMqh4nsdmdkaapVnRMn5gecgosBeuoRdl1Vj9ABEmvYW2vLegogqhUL7xG09_9FX6N7k5PpYX74-ejgOdpOgNa5iJk4e4E2m-XKvARa1hSv2jn4B6eAOUY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwGLWgSKNe2JdhNRInpKxe4nArU0aFMtWoolIlDpHjhRmVJqNJpgj-FH-Rz3FSMVVPzTFxYkd-9ve--OUZoXdxaoA1cBsIa3hAGdOBkBkP8pIRC3RCUeb-d54d8YMT-uWUnfaqyqaXVVaqXIbVz_OwWi46beXqXEWDTiyazybA4YEWZyRaaRvdRndg0KbZkKn3szDEbT8LQ7rM4PArmimhcSRVK_VFeAGZSEhd_NtFI0cTGBPpVnjqXPyvo55XFZT_haTpPfR9eBmvRDkLN20Zqj9XfB5v9rb30d2eqeI9X-YBumWqh2g069fiH6G_zv1Jdv8sYVlpDDON36AU1xbPm3rtOl25-xedcRLu9jXCc2_k2mD3Bbgv17ir8IjjZXOGp34HIAxs-trHLCt8bLw7t6vpsAba-wHvYe_w_QvagPdlK114xpN6AekFdmLJ34_RyfTTt8lB0G__EChCRRuIPLZa0cRAzphaCZ0Ty1hLZiGs21QICqlvqYDiCCJlZhOd5pYTSBBFJpTkijxBO1VdmWcIa15K4CapVVxQKJxDeDA8V9rmJc0TMkbvh14vVt7lo4DsyKGl8GgpHFqKDi1j9NHh4rKgM-juTtTrH0XfcUWSSsVyJ0HJSspiIpksjdWa5NqQTECNbwdUFTCg3SqNrEy9aQriTP2AW3AxRk89yi6rGlA6RmILf1tt2b4CqOpMwwcUPb_5rW_QaL4_Lb5-Pjp8gXZTYHdOOJPkL9FOu96YV8DO2vJ1Nwz_AU7cO8Y |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Incidence+of+Psoriatic+Arthritis+among+Patients+with+Psoriasis+and+Risk+Factors+for+Psoriatic+Arthritis+in+Republic+of+Korea%3A+A+Nationwide+Database+Cohort+Study&rft.jtitle=Acta+dermato-venereologica&rft.au=Chul+Hwan+Bang&rft.au=Yoon-Seob+Kim&rft.au=Jihye+An&rft.au=Eun+Suk+Jung&rft.date=2024-09-19&rft.pub=Medical+Journals+Sweden&rft.issn=0001-5555&rft.eissn=1651-2057&rft.volume=104&rft_id=info:doi/10.2340%2Factadv.v104.40110&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_12ac5910077b4503a5abefdd39de3783 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-5555&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-5555&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-5555&client=summon |